Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Repurchased
Ratios

Resmed (RSMDF) Long-Term Debt Issuances (2016 - 2023)

Historic Long-Term Debt Issuances for Resmed (RSMDF) over the last 13 years, with Q3 2023 value amounting to $105.0 million.

  • Resmed's Long-Term Debt Issuances rose 11000.0% to $105.0 million in Q3 2023 from the same period last year, while for Jun 2024 it was $105.0 million, marking a year-over-year decrease of 9018.69%. This contributed to the annual value of $105.0 million for FY2024, which is 9018.69% down from last year.
  • Latest data reveals that Resmed reported Long-Term Debt Issuances of $105.0 million as of Q3 2023, which was up 11000.0% from $1.0 billion recorded in Q4 2022.
  • Resmed's Long-Term Debt Issuances' 5-year high stood at $1.0 billion during Q4 2022, with a 5-year trough of $10.0 million in Q4 2021.
  • In the last 5 years, Resmed's Long-Term Debt Issuances had a median value of $139.0 million in 2021 and averaged $226.5 million.
  • Per our database at Business Quant, Resmed's Long-Term Debt Issuances crashed by 9026.55% in 2020 and then surged by 1010000.0% in 2022.
  • Over the past 5 years, Resmed's Long-Term Debt Issuances (Quarter) stood at $165.0 million in 2019, then plummeted by 66.67% to $55.0 million in 2020, then crashed by 81.82% to $10.0 million in 2021, then surged by 10100.0% to $1.0 billion in 2022, then plummeted by 89.71% to $105.0 million in 2023.
  • Its last three reported values are $105.0 million in Q3 2023, $1.0 billion for Q4 2022, and $50.0 million during Q3 2022.